halmek holdings Co.,Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥19 | -45.7% |
| 2025 | ¥35 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥28,738M | ¥31,415M | ¥33,930M | ¥33,812M |
| Gross Profit | ¥16,138M | ¥17,755M | ¥19,095M | ¥19,043M |
| Operating Income | ¥2,032M | ¥857M | ¥1,069M | ¥1,774M |
| Pretax Income | ¥2,030M | ¥857M | ¥1,069M | ¥1,780M |
| Net Income | ¥1,248M | ¥476M | ¥623M | ¥1,051M |
| EPS | ¥147.16 | ¥42.63 | ¥56.24 | ¥94.15 |
| Operating Margin | 7.07% | 2.73% | 3.15% | 5.25% |
| Balance Sheet | ||||
| Total Assets | ¥23,097M | ¥20,114M | ¥20,893M | ¥21,164M |
| Total Equity | ¥6,482M | ¥7,555M | ¥8,195M | ¥8,893M |
| Total Liabilities | ¥16,615M | ¥12,559M | ¥12,698M | ¥12,271M |
| Cash | ¥5,036M | ¥938M | ¥2,394M | ¥2,778M |
| Interest-bearing Debt | ¥8,124M | ¥4,944M | ¥4,807M | ¥4,537M |
| Equity Ratio | 28.06% | 37.56% | 39.22% | 42.02% |
| D/E Ratio | 1.25 | 0.65 | 0.59 | 0.51 |
| Cash Flow | ||||
| Operating CF | ¥2,260M | ¥152M | ¥2,395M | ¥1,698M |
| Investing CF | -¥464M | -¥414M | -¥344M | -¥380M |
| Financing CF | ¥2,275M | -¥3,836M | -¥593M | -¥934M |
| Free CF | ¥1,852M | -¥230M | ¥2,057M | ¥1,340M |
| Efficiency | ||||
| ROE | 19.25% | 6.30% | 7.60% | 11.82% |
| ROA | 5.40% | 2.37% | 2.98% | 4.97% |
Latest IR Information
-
Notice of Completion of Payment for New Share Issuance as Restricted Stock
Payment for the new share issuance has been completed. Number of issued shares: 12,767 shares, issue price: 1,669 yen, total amount: 21,308,123 yen. Allottees: 4 directors and 6 executive officers.
Read more -
(Halmek Holdings Co., Ltd.) 2027 Fiscal Year Q1 Financial Summary
Consolidated results for the first quarter of the 2027 fiscal year have been announced. Key indicators such as sales, operating income, and quarterly net income, along with the financial condition and cash flows, are disclosed. The financial position is described...
Read more -
Q1 2027 Fiscal Year Financial Results Briefing Supplement Data
For FY2027 March-term, revenue is expected between 380 and 400 billion yen, operating profit between 2 and 3 billion yen, ROE around 13–16%, and dividend payout ratio around 35%. Segment-wise, Halumeku retail and information content are the main drivers. Active...
Read more -
First Quarter Financial Summary for the Fiscal Year Ending March 2027
disclosed the first quarter results for the fiscal year ending March 2027. Reports on trends in key indicators such as revenue, operating income, and ordinary income. Outlines progress of structural reforms, outlook, and segment-by-segment information, along with section highlights.
Read more -
Notice Regarding Expansion of the Shareholder Benefits Program
Decision to expand the shareholder benefits program. Includes expansion of eligible share numbers, refresh and enhancement of benefits, and guidance on timing of implementation. Specific amounts and dates depend on the main text; the summary provides an overview of the...
Read more
Latest News (5 items)
Company Information
About
halmek holdings Co.,Ltd. engages in the content, mail order, store, consulting and advertising agency, and healthcare businesses in Japan. The company provides magazines, websites, courses, and events to support adult women; engages in the mail order and sale of health and life, and fashion products; and operates retail stores that provide fashion products, shoes, cosmetics, food products, health foods, health care products, daily necessities, and underwears. It also offers consulting and advertising agency services, such as media sales, customer attraction support, CRM consulting, new business development support, mail order startup, and senior research; and at home and cognitive function check, and hospital referral and health consultation services. The company was founded in 1989 and is headquartered in Tokyo, Japan.
